interactions with tirzepatide patientsafety #glp1 #tirzepatide #obesitymedicine #elililly | Joseph Zucchi, PA-C, MPAS 2D 1 H-13 C HSQC

The fear of complications keeps you awake at night

In the matched cohort of 9,424 pairs of patients on GLP-1RA and SGLT2i with a median follow-up of 2.9 years, there was no difference in the risk for AF (IRD, 0.4

Hemolytic conditions are associated with rupture of cell membranes and liberation of hemoglobin, its derivatives like methemoglobin or ferrylhemoglobin, heme, and other erythrocyte-derived molecules like ATP, IL-33, or HSP70 [62]

This structural difference affects stability, bioavailability, and conversion requirements in the body

These trials test the safety, effectiveness, and potential side effects of the medication